Amicus Therapeutics, Inc.
Doing business as (A Development Stage Company)
- UEI
- FJDHZ9PWMZ14
- CAGE
- 603U6
- Primary NAICS
- 541711 Research and Development in Biotechnology
- SAM.gov registration
- Expired
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
- Philadelphia, PA KLJFGENKMD89
- R6W1NLLM6K39
-
- SAM.gov registration date
- Website
- amicusrx.com
- Founded
- 2002
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations
Most of Amicus Therapeutics, Inc.'s contract dollars go to its subsidiaries: $821 thousand across 1 awardee in NAICS 325412 in FY2025.
Similar vendors
About the company
Amicus Therapeutics, Inc. is a corporate entity registered in SAM.gov since May 17, 2010, operating as a for-profit organization with a focus on contracts and grants. As a development-stage company, the organization appears to be primarily engaged in pharmaceutical and biotechnology research and development. The company is structured as a parent entity with capabilities to receive federal contract vehicles, though current records indicate no prime contract or grant awards have been directly secured.
Based on the available vendor registration information, there are no specific details about past federal contract performance or specific goods and services provided to federal agencies. The vendor's SAM.gov registration expired on June 26, 2014, which suggests potential gaps in continuous federal contracting eligibility. Without additional context from federal procurement databases or company records, a comprehensive assessment of their federal contract history cannot be definitively established.
The vendor's registration indicates an awarded federal contract vehicle exists, but no detailed information is provided about specific indefinite delivery vehicles (IDVs), task order mechanisms, or associated federal agencies. The lack of prime awardee status for both contracts and grants implies that Amicus Therapeutics, Inc. may have limited direct federal procurement engagement during the period covered by this registration record. Further investigation through additional procurement systems would be necessary to confirm the full extent of the company's federal contracting landscape.
Quick answers
Is Amicus Therapeutics, Inc. registered in SAM.gov?
Amicus Therapeutics, Inc.'s SAM.gov registration expired on June 26, 2014.
What is Amicus Therapeutics, Inc.'s CAGE code?
Amicus Therapeutics, Inc.'s CAGE code is 603U6, and its Unique Entity ID (UEI) is FJDHZ9PWMZ14.
How does Amicus Therapeutics, Inc. rank among federal contractors?
Amicus Therapeutics, Inc. ranked #71 in NAICS 325412 and #100 in PSC 6505 in FY2025.
On GovTribe
See Amicus Therapeutics, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors